Skip to main content

Invesco Ltd.

Position in NVO — Novo Nordisk A S

CIK 914208 Atlanta, GA

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$32,892,638
+$314,647 QoQ
Shares Held
686,121
-22.6% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $27,851,957,097 across 16 Drug Manufacturers - General names. NVO ranks #12 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $32,892,638 686,121
2026-03-31 $32,577,991 886,476
2025-12-31 $32,140,334 631,689
2025-09-30 $29,076,425 523,994
2025-06-30 $28,967,070 419,691
2025-03-31 $23,069,632 332,224
2024-12-31 $30,038,870 349,208
2024-09-30 $61,970,217 520,452
2024-06-30 $117,209,664 821,141
2024-03-31 $109,609,042 853,653
2023-12-31 $78,260,541 756,506
2023-09-30 $52,260,214 574,667
2023-06-30 $46,503,305 287,359
2023-03-31 $35,278,948 221,685
2022-12-31 $25,177,840 186,034
2022-09-30 $21,211,624 212,904
2022-06-30 $31,781,840 285,218
2022-03-31 $81,463,946 733,579
2021-12-31 $47,962,992 428,241
2021-09-30 $29,627,437 308,587
2021-06-30 $27,043,468 322,830
2021-03-31 $22,160,885 328,699
2020-12-31 $23,797,265 340,691
2020-09-30 $24,674,934 355,393
2020-06-30 $16,648,551 254,254
2020-03-31 $9,622,066 159,835